Royal Bank of Canada’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-992
| Closed | -$6K | – | 7321 |
|
|
2025
Q4 | $6K | Sell |
992
-97
| -9% | -$548 | ﹤0.01% | 6635 |
|
|
2025
Q3 | $7K | Buy |
1,089
+787
| +261% | +$4.08K | ﹤0.01% | 6596 |
|
|
2025
Q2 | $1K | Sell |
302
-223
| -42% | -$859 | ﹤0.01% | 6882 |
|
|
2025
Q1 | $2K | Sell |
525
-274
| -34% | -$1.93K | ﹤0.01% | 6564 |
|
|
2024
Q4 | $9K | Sell |
799
-385
| -33% | -$6.86K | ﹤0.01% | 6370 |
|
|
2024
Q3 | $30K | Buy |
1,184
+117
| +11% | +$3.09K | ﹤0.01% | 5927 |
|
|
2024
Q2 | $30K | Buy |
1,067
+364
| +52% | +$11.8K | ﹤0.01% | 5887 |
|
|
2024
Q1 | $28K | Sell |
703
-1,305
| -65% | -$30.7K | ﹤0.01% | 5776 |
|
|
2023
Q4 | $33K | Buy |
2,008
+394
| +24% | +$6.87K | ﹤0.01% | 6153 |
|
|
2023
Q3 | $61K | Buy |
1,614
+506
| +46% | +$24K | ﹤0.01% | 5671 |
|
|
2023
Q2 | $61K | Buy |
1,108
+200
| +22% | +$9.18K | ﹤0.01% | 5673 |
|
|
2023
Q1 | $40K | Sell |
908
-380
| -30% | -$18.4K | ﹤0.01% | 5734 |
|
|
2022
Q4 | $50K | Buy |
1,288
+594
| +86% | +$31.2K | ﹤0.01% | 5877 |
|
|
2022
Q3 | $37K | Buy |
694
+33
| +5% | +$2.06K | ﹤0.01% | 5891 |
|
|
2022
Q2 | $43K | Sell |
661
-243
| -27% | -$15.9K | ﹤0.01% | 5777 |
|
|
2022
Q1 | $67K | Sell |
904
-712
| -44% | -$41.3K | ﹤0.01% | 5899 |
|
|
2021
Q4 | $113K | Buy |
1,616
+1,046
| +184% | +$183K | ﹤0.01% | 5844 |
|
|
2021
Q3 | $143K | Buy |
570
+132
| +30% | +$31.6K | ﹤0.01% | 5443 |
|
|
2021
Q2 | $118K | Sell |
438
-186
| -30% | -$55.6K | ﹤0.01% | 5496 |
|
|
2021
Q1 | $178K | Buy |
624
+411
| +193% | +$132K | ﹤0.01% | 5037 |
|
|
2020
Q4 | $60K | Buy |
213
+173
| +433% | +$55.5K | ﹤0.01% | 5585 |
|
|
2020
Q3 | $12K | Hold |
40
| – | – | ﹤0.01% | 5866 |
|
|
2020
Q2 | $8K | Buy |
+40
| New | +$8.91K | ﹤0.01% | 5910 |
|
Other funds holding GBIO
Royal Bank of Canada's GBIO Position: Q1 2026 in Review
Royal Bank of Canada sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 992 shares — an estimated $6K sold.
Royal Bank of Canada first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $178K in Q1 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Royal Bank of Canada reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Royal Bank of Canada sold 992 Generation Bio shares in Q1 2026, an estimated $6K.
- Royal Bank of Canada first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
- Royal Bank of Canada's Generation Bio position peaked at $178K in Q1 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.